ILMN

Illumina
D

ILMN

102.085
USD
2.84
(2.86%)
مغلق
حجم التداول
49,459
الربح لكل سهم
5
العائد الربحي
-
P/E
13
حجم السوق
15,690,464,500
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ سنة
buy
2024-07-24 05:43
ILMN Chart
المزيد
أصول ذات صلة الأخبار المقالات

العنوان: Illumina

القطاع: Healthcare
الصناعة: Diagnostics & Research
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.